Lantern Pharma Inc. (NASDAQ:NASDAQ:LTRN) Q1 2022 Earnings Conference Call May 3, 2022 16:30 ET Company Participants Nicole Leber - Investor Relations Associate, Finance & Administrative.
FDA Separately Grants Lantern Pharma and Codexis Rare Pediatric Disease Designations globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Lantern Pharma (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR® artificial intelligence ("A.I.") platform.
Preclinical Data on New Pancreatic Cancer Drug Shines with over 90% Efficacy biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.